PTPRC and neoplasm: Besides HER2+ CTCs (DAPI+/CK+/HER2+/CD45−) enumeration by RUBYchipTM and CellSearch®, liquid biopsy findings were compared with the histopathological assessment of HER2 status from the tissue biopsy of the primary tumour (Figure 6).